Analysis of the type 2 diabetes-associated single nucleotide polymorphisms in the genes IRS1, KCNJ11 and PPARG2 in type 1 diabetes

被引:36
作者
Eftychi, C
Howson, JMM
Barratt, BJ
Vella, A
Payne, F
Smyth, DJ
Twells, RCJ
Walker, NM
Rance, HE
Tuomilehto-Wolf, E
Tuomilehto, J
Undlien, DE
Ronningen, KS
Guja, C
Ionescu-Tîrgoviste, C
Savage, DA
Todd, JA
机构
[1] Univ Cambridge, Cambridge Inst Med Res, JDRF, Wellcome Trust Diabet & Inflammat Lab, Cambridge CB2 2XY, England
[2] Univ Helsinki, Natl Publ Hlth Inst, Diabet & Genet Epidemiol Unit, Helsinki, Finland
[3] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland
[4] Univ Oslo, Ulleval Univ Hosp, Oslo, Norway
[5] Norwegian Inst Publ Hlth, Div Epidemiol, Lab Mol Epidemiol, Oslo, Norway
[6] Inst Diabet Nutr & Metab Dis, Diabet Clin, Bucharest, Romania
[7] Queens Univ Belfast, Belfast City Hosp, Dept Med Genet, Belfast, Antrim, North Ireland
关键词
D O I
10.2337/diabetes.53.3.870
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It has been proposed that type 1 and 2 diabetes might share common pathophysiological pathways and, to some extent, genetic background. However, to date there has been no convincing data to establish a molecular genetic link between them. We have genotyped three single nucleotide polymorphisms associated with type 2 diabetes in a large type 1 diabetic family collection of European descent: Gly972Arg in the insulin receptor substrate 1 (IRS1) gene, Glu23Lys in the potassium inwardly-rectifying channel gene (KCNJ11), and Pro12AIa in the peroxisome proliferative-activated receptor gamma2 gene (PPARG2). We were unable to confirm a recently published association of the IRS1 Gly972Arg variant with type 1 diabetes. Moreover, KCNJ11 Glu23Lys showed no association with type 1 diabetes (P>0.05). However, the PPARG2 Pro12AIa variant showed evidence of association (RR 1.15, 95% CI 1.04-1.28, P=0.008). Additional studies need to be conducted to confirm this result.
引用
收藏
页码:870 / 873
页数:4
相关论文
共 30 条
  • [1] Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-γ expression in splenic T cells
    Augstein, P
    Dunger, A
    Heinke, P
    Wachlin, G
    Berg, S
    Hehmke, B
    Salzsieder, E
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 304 (02) : 378 - 384
  • [2] THE BRITISH-DIABETIC-ASSOCIATION - WARREN REPOSITORY
    BAIN, SC
    TODD, JA
    BARNETT, AH
    [J]. AUTOIMMUNITY, 1990, 7 (2-3) : 83 - 85
  • [3] Troglitazone prevents insulin dependent diabetes in the non-obese diabetic mouse
    Beales, PE
    Liddi, R
    Giorgini, AE
    Signore, A
    Procaccini, E
    Batchelor, K
    Pozzilli, P
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 357 (2-3) : 221 - 225
  • [4] Thiazolidinediones for the prevention of diabetes in the non-obese diabetic (NOD) mouse: implications for human type 1 diabetes
    Beales, PE
    Pozzilli, P
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2002, 18 (02) : 114 - 117
  • [5] Human type 1 diabetes and the insulin gene: Principles of mapping polygenes
    Bennett, ST
    Todd, JA
    [J]. ANNUAL REVIEW OF GENETICS, 1996, 30 : 343 - 370
  • [6] IRS proteins and β-cell function
    Burks, DJ
    White, MF
    [J]. DIABETES, 2001, 50 : S140 - S145
  • [7] A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data:: Application to HLA in type 1 diabetes
    Cordell, HJ
    Clayton, DG
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 70 (01) : 124 - 141
  • [8] Parameters for reliable results in genetic association studies in common disease
    Dahlman, I
    Eaves, IA
    Kosoy, R
    Morrison, VA
    Heward, J
    Gough, SCL
    Allahabadia, A
    Franklyn, JA
    Tuomilehto, J
    Tuomilehto-Wolf, E
    Cucca, F
    Guja, C
    Ionescu-Tirgoviste, C
    Stevens, H
    Carr, P
    Nutland, S
    McKinney, P
    Shield, JP
    Wang, W
    Cordell, HJ
    Walker, N
    Todd, JA
    Concannon, P
    [J]. NATURE GENETICS, 2002, 30 (02) : 149 - 150
  • [9] DAHLQUIST G, 1989, DIABETOLOGIA, V32, P2
  • [10] A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity
    Deeb, SS
    Fajas, L
    Nemoto, M
    Pihlajamäki, J
    Mykkänen, L
    Kuusisto, J
    Laakso, M
    Fujimoto, W
    Auwerx, J
    [J]. NATURE GENETICS, 1998, 20 (03) : 284 - 287